Global Medical Microbiology Testing Technologies Market: Overview
This report provides forecast and analysis of the medical microbiology testing technologies market on the global and regional levels. It provides historical data of 2015 along with forecast from 2016 to 2024 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook on medical microbiology testing technologies globally. It includes drivers and restraints of the medical microbiology testing technologies market and their impact on each region during the forecast period. The report also comprises the study of current issue and opportunities for medical microbiology testing manufacturers.
Look for the Research Report Details at: http://www.transparencymarketresearch.com/microbiology-testing-technologies-market.html
In order to provide users of this report with comprehensive view of the market, we have included detailed competitiveness analysis and company players. The dashboard provides detailed comparison of medical microbiology testing manufacturers on parameters such as operating margin, unique selling propositions, collective market share, and geographic concentration. The study encompasses market attractiveness analysis, by indication, type, technology type, application type, end user type and region.
Europe to Lead the Pack as Uptake of Technology Improves
Geographically, this global medical microbiology testing technologies market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The report suggests that Europe and North America will offer the global market lucrative opportunities in the near future. Europe is estimated to dominate the global market as the regional market expands at a CAGR of 4.8% between 2016 and 2024. The growing demand for improved microbiology technologies in the region is expected to boost the demand in the coming years.
On the basis of indication, the global market for medical microbiology testing technologies is categorized into respiratory diseases, neurological diseases, infectious diseases, and others. Of all these segments, the infectious diseases segment is expected to acquire a share of 41% in the global market by the end of 2024 in terms of volume. The high incidence of infectious diseases across the globe is expected to drive this segment in the near future.
Increasing Government Investments Boost Global Market
The growing government investments in the research of life sciences and biological and medical sciences are largely responsible for the accelerated pace of growth of the overall market. The report predicts that government investments are likely to continue in the coming years as this research is characterized by high risk and long duration, which makes it unattractive for companies looking to make quick profits. The market is also expected to be driven by the high prevalence of infectious diseases and emerging infectious diseases, especially among the population of the developing nations. The commonly seen infectious diseases affecting individuals across the globe are impetigo, urinary tract infections, and pneumonia. Furthermore, the growing demand for automation in medical microbiology for specimen management, nucleic acid amplification, identification, microbial detection, and susceptibility testing is also estimated to benefit the global market.
Perceive the Premium Research Report for Medical Microbiology Testing Technologies Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11603
High Costs and Complex Procedures Restrain Global Market
The global medical microbiology testing technologies market is being restrained by the high cost associated with various types of media. Analysts anticipate that the global market will also be held back due to the complexities involved in sample preparation techniques. The premium pricing of using medical microbiology technologies are also projected to limit the growth of the global market through the forecast period. Lastly, the impact of point-of-care testing is also proving to be a negative one on the overall market.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453